Bringing the fundamentals into focus…
Back to Axsome Therapeutics, Inc.
How Axsome Therapeutics, Inc. stacks up
AXSM · against 197 other Healthcare companies of similar size
Overall
32/ 100
Near the bottom of its peers.
Ranked #175 of 198 · scores higher than 11% of peers
Bars: peers in each 10-point band of the overall score26 peers with an overall score of 30–39, including AXSM · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around AXSM| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 2 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 3 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 4 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 5 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 170 | 5.1B USD | 35 | 8 | — | 12 | 0 / 2 | |
| 170 | 10.8B USD | 35 | 49 | 31 | 41 | 2 / 2 | |
| 173 | 4.5B USD | 33 | 33 | — | 16 | 1 / 2 | |
| 173 | 9.0B USD | 33 | 8 | — | 23 | 1 / 2 | |
| 175 | 7.3B USD | 32 | 8 | 92 | 21 | 2 / 2 | |
| 175 | 6.0B USD | 32 | 8 | 91 | 16 | 2 / 2 | |
| 177 | 3.7B USD | 31 | 8 | 8 | 13 | 0 / 2 | |
| 177 | 8.8B USD | 31 | 8 | 99 | 10 | 2 / 2 | |
| 177 | 14.0B USD | 31 | 8 | 88 | 25 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score